Myeloproliferative Neoplasms Clinical Trials in Chicago, Illinois
3 recruitingChicago, Illinois
Showing 1–3 of 3 trials
Recruiting
Phase 1
A Study to Evaluate the Safety, Tolerability of INCB160058 in Participants With Myeloproliferative Neoplasms
Myeloproliferative Neoplasms
Incyte Corporation186 enrolled31 locationsNCT06313593
Recruiting
Phase 1
A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
Myeloproliferative Neoplasms
Incyte Corporation120 enrolled26 locationsNCT07008118
Recruiting
Phase 1
Ivosidenib and Ruxolitinib in Patients With Advanced Myeloproliferative Neoplasms (MPNs) That Have an IDH1 Gene Mutation
Myeloproliferative Neoplasms
University of Chicago18 enrolled1 locationNCT06291987